Here, we demonstrated that the expression levels of HLA-DP, -DQ, -DR, and -DM were significantly lower in Stage II than in Stage I cutaneous melanoma, while there was a tendency toward gradual increase in HLA class II gene expressions from Stage II to Stage IV (Figure 2). Here, HLA-DPB1 is linked to cutaneous melanoma.